ANNX Annexon Inc. - Annexon to Present Phase 2 Archer Baseline Characteristics Associated with Confirmed Best Corrected Visual Acuity 15-Let

ANNX Annexon Inc. - Annexon to Present Phase 2 Archer Baseline Characteristics Associated with Confirmed Best Corrected Visual Acuity 15-Letter Loss in Patients with Geographic Atrophy at ASRS 2026